Executive Function Training for Binge Eating Disorder and Comorbid Mood/Anxiety Disorders
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Binge-Eating Disorder
- Sponsor
- University of California, San Diego
- Enrollment
- 39
- Locations
- 1
- Primary Endpoint
- Feasibility as measured by number of treatment sessions attended
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
Binge Eating Disorder (BED) is the most common eating disorder, and currently, the best behavioral treatments only work for 40-60% of adults. BED often co-occurs with mood and anxiety disorders, and both are associated with neurocognitive deficits related to executive function (EF). These EF deficits contribute to worsening BED symptoms and make it difficult for these adults to adhere to treatment recommendations. The proposed study aims to develop an EF training enhanced behavioral treatment for BED and compare its effectiveness to the standard cognitive behavioral therapy for patients with BED and a co-occurring mood or anxiety disorder.
Detailed Description
A randomized controlled trial (RCT) will evaluate an EF training enhanced cognitive behavioral therapy (CBT) for BED (EF-BED+CBT) compared to standard CBT in patients with BED and a comorbid mood/anxiety disorder to assess the feasibility, acceptability, and preliminary efficacy of EF-BED+CBT in reducing binge eating, impairment, and comorbid depression/anxiety symptoms. Adult participants with BED and comorbid mood/anxiety disorder will be randomized to a four month remote treatment of either EF-BED+CBT or CBT alone. Participants will be assessed at baseline, following treatment (month 4) and 2-month follow-up (month 6).
Investigators
Dawn Eichen
Assistant Adjunct Professor
University of California, San Diego
Eligibility Criteria
Inclusion Criteria
- •Age 18-65
- •Ability to read English at a 6th grade level
- •Clinical or subclinical BED and at least one comorbid mood or anxiety disorder
Exclusion Criteria
- •Known cognitive disability (e.g., brain injury with loss of consciousness \>30 min, intellectual disability)
- •Psychosis
- •Psychiatric condition that could interfere with program participation (e.g., substance abuse, suicide attempt within previous 6 months, active purging, active suicidality)
- •Currently pregnant, lactating or plan to be in the timespan of program follow-up
- •Change in psychotropic medication or other medication that could have impact on weight, binge eating or anxiety/mood symptoms during the previous 3 months
- •Participating in an organized program for overeating
Outcomes
Primary Outcomes
Feasibility as measured by number of treatment sessions attended
Time Frame: Over the course of 4 months of treatment
Attendance at Treatment Sessions
Acceptability
Time Frame: At 4 months
Ratings of usefulness of treatment measured by responses to Likert-type ratings developed by the study team.
Secondary Outcomes
- Binge Eating(Through study completion, an average of 6 months)
- Impairment(Through study completion, an average of 6 months)